Akero Therapeutics, Inc. - Common Stock, par value $0.0001 per share (AKRO)

211 filings reported holding AKRO - Akero Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2024.
Akero Therapeutics, Inc. - Common Stock, par value $0.0001 per share (AKRO) has 172 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 73.1M shares of 80M outstanding shares and own 91.35% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (6.12M shares), RTW INVESTMENTS, LP (5.43M shares), GENERAL ATLANTIC, L.P. (5.23M shares), WELLINGTON MANAGEMENT GROUP LLP (5.21M shares), BlackRock Inc. (4.89M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.06M shares), STATE STREET CORP (3.8M shares), VANGUARD GROUP INC (3.67M shares), ALKEON CAPITAL MANAGEMENT LLC (3.33M shares), and BAKER BROS. ADVISORS LP (2.71M shares).
This table shows the top 172 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.